Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin in acquired von Willebrand syndrome caused by aortic valve stenosis
2005-004559-36Phase 4Completed
- Sponsor
- Abteilung für Herz-Thorax-Gefäß Anästhesie & Intensivmedizin (HTG)
- Start
- Feb 2006
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, single-arm trial of desmopressin in von Willebrand disease (VWD) and aortic stenosis (AS), sponsored by Abteilung für Herz-Thorax-Gefäß Anästhesie & Intensivmedizin (HTG). Primary endpoint: von Willebrand factor antigen (vWF:Ag). Started Feb 2006; status: completed.
02
Drugs
desmopressin
03
Conditions
von Willebrand disease (VWD)aortic stenosis (AS)
Beyond the preview
Go deeper on 2005-004559-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004559-36.